About GenomOncology
GenomOncology is a company based in Cleveland (United States) founded in 2012.. GenomOncology has raised $6.09 million across 5 funding rounds from investors including TriStar Health Partners and JumpStart Ventures. GenomOncology offers products and services including Precision Oncology Platform, Data Enablement, Pathology Decision Support, Insights & Analytics, and Curation Services. GenomOncology operates in a competitive market with competitors including Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others.
- Headquarter Cleveland, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genomoncology Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.09 M (USD)
in 5 rounds
-
Latest Funding Round
$3.2 M (USD), Series A
Apr 24, 2020
-
Investors
TriStar Health Partners
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GenomOncology
GenomOncology offers a comprehensive portfolio of products and services, including Precision Oncology Platform, Data Enablement, Pathology Decision Support, Insights & Analytics, and Curation Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Transforms complex data into actionable insights for cancer care.
Harnesses data to enhance operational efficiency in healthcare.
Processes genetic test results for clinical insights.
Analyzes patient data to improve cancer care outcomes.
Provides curated content for precision oncology solutions.
Unlock access to complete
Unlock access to complete
Funding Insights of GenomOncology
GenomOncology has successfully raised a total of $6.09M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $3.2 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $3.2M
-
First Round
First Round
(08 May 2012)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2020 | Amount | Series A - GenomOncology | Valuation |
investors |
|
| Nov, 2019 | Amount | Seed - GenomOncology | Valuation |
investors |
|
| Feb, 2014 | Amount | Seed - GenomOncology | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GenomOncology
GenomOncology has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include TriStar Health Partners and JumpStart Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided to tech startups by JumpStart Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GenomOncology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GenomOncology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genomoncology Comparisons
Competitors of GenomOncology
GenomOncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genomoncology
Frequently Asked Questions about GenomOncology
When was GenomOncology founded?
GenomOncology was founded in 2012.
Where is GenomOncology located?
GenomOncology is headquartered in Cleveland, United States. It is registered at Cleveland, Ohio, United States.
Is GenomOncology a funded company?
GenomOncology is a funded company, having raised a total of $6.09M across 5 funding rounds to date.
What does GenomOncology do?
GenomOncology is a healthcare technology company enabling precision medicine by transforming genomic data into actionable information. It has developed a proprietary technology platform to streamline the use of next-generation sequencing in medicine and research. Precision Medicine Portfolio is a suite of products and services that addresses for precision medicine in molecular pathology and medical genetics, particularly in the field of oncology and other hereditary diseases. This portfolio supports test validation and production, clinical decision support, and analytics for both monitoring and discovery. Its other products include the GO Validation Toolkit, the GO Clinical Workbench, and GenomAnalytics. It also offers scientific services like test validation, customization, integration, and research.
Who are the top competitors of GenomOncology?
GenomOncology's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
What products or services does GenomOncology offer?
GenomOncology offers Precision Oncology Platform, Data Enablement, Pathology Decision Support, Insights & Analytics, and Curation Services.
Who are GenomOncology's investors?
GenomOncology has 2 investors. Key investors include TriStar Health Partners, and JumpStart Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.